• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Solasia initiates Phase III programme for PledOx biospectrumasia
    January 07, 2019
    In November 2017, Solasia acquired exclusive development and commercialization rights for PledOx in Japan, Mainland China, Hong Kong, S.A.R., China Region in China, Macau, S.A.R., China Region in China, Taiwan, China Region in China, South Korea and from

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service